Watch CLPT. Know when insiders buy.
One email the day a filing lands. Free.
CLPT
ClearPoint Neuro, Inc.
13.88
−0.17 −1.21%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
17
FLAG · shorts 17
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $423.4MP/E —DIV YIELD —FCF YIELD -7.38%REV TTM $42.3M +25.9%NET INCOME −$34.6MNET DEBT $20.9M52W 8.66 – 29.60SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $10.9M | +18.1% | 61.7% | −$10.2M | −$11.3M | — | -0.38 | −$7M | $214K | −$7.2M | Aug 3 |
| Q1 2026 · Mar 31 | $12.1M | +42.9% | 64.0% | −$8.5M | −$9.6M | — | -0.32 | −$8M | $645K | −$8.6M | Aug 3 |
| Q4 2025 · Dec 31derived | $10.4M | +34.0% | 61.5% | −$7M | −$7.8M | — | -0.27 | −$12.1M | $49K | −$12.1M | Aug 3 |
| Q3 2025 · Sep 30 | $8.9M | +9.1% | 63.2% | −$5.3M | −$5.9M | — | -0.21 | −$3.1M | $199K | −$3.3M | Nov 6 |
| Q2 2025 · Jun 30 | $9.2M | +17.3% | 60.3% | −$5.7M | −$5.8M | — | -0.21 | −$2.6M | $91K | −$2.6M | Aug 3 |
| Q1 2025 · Mar 31 | $8.5M | +11.1% | 60.5% | −$6.2M | −$6M | — | -0.22 | −$6.2M | $183K | −$6.4M | Aug 3 |
| Q4 2024 · Dec 31derived | $7.8M | +14.1% | 61.3% | −$5.6M | −$5.4M | — | -0.20 | −$1.2M | $263K | −$1.5M | Mar 17 |
| Q3 2024 · Sep 30 | $8.1M | +41.0% | 59.7% | −$5.2M | −$5M | — | -0.18 | −$1.2M | $12K | −$1.2M | Nov 6 |
| Q2 2024 · Jun 30 | $7.9M | — | 63.5% | −$4.7M | −$4.4M | — | -0.16 | −$2.7M | $0 | −$2.7M | Nov 6 |
| Q1 2024 · Mar 31 | $7.6M | — | 59.2% | −$4.2M | −$4.1M | — | -0.16 | −$3.8M | $0 | −$3.8M | Nov 6 |
| Q4 2023 · Dec 31derived | $6.8M | — | 58.9% | −$4.7M | −$4.6M | — | -0.19 | −$1.2M | $21K | −$1.2M | Feb 26 |
| Q3 2023 · Sep 30 | $5.8M | — | 56.8% | −$4.9M | −$4.8M | — | -0.20 | −$1.8M | $235K | −$2M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $37M | 61.4% | −$24.2M | −$25.5M | -69.1% | -0.90 | −$23.9M | $522K | −$24.4M | — | — |
| FY2024 · to Dec 31 | $31.4M | 60.9% | −$19.7M | −$18.9M | -60.3% | -0.70 | −$8.9M | $275K | −$9.2M | — | — |
| FY2023 · to Dec 31 | $24M | 56.8% | −$22.4M | −$22.1M | -92.2% | -0.90 | −$13.7M | $717K | −$14.4M | — | — |
| FY2022 · to Dec 31 | $20.6M | 65.8% | −$16.3M | −$16.4M | -80.0% | -0.68 | −$16.2M | $253K | −$16.4M | — | — |
| FY2021 · to Dec 31 | $16.3M | 68.2% | −$13.4M | −$14.4M | -88.4% | -0.69 | −$12.7M | $168K | −$12.9M | — | — |
| FY2020 · to Dec 31 | $12.8M | 71.1% | −$6.2M | −$6.8M | -52.9% | -0.43 | −$7.8M | $41K | −$7.8M | — | — |
Every number comes from ClearPoint Neuro, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.